Search global stocks & ETFs...Ctrl K

Learn Mode

A - Agilent Technologies Inc

70

$111.70

-$1.56 (-1.377%)

At close: 5/15/26, 8:00 PM

Score

3.71/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$31.57B

Industry

Life Sciences Tools & Services

EPS (TTM)

$4.53

P/E (TTM)

24.47

Div & Yield

$1.02 (0.91%)

FCF Payout Ratio

29.03%

P/S (TTM)

4.47

P/B

4.57

Diluted Shares

284.00M

Ex-Dividend

2026-03-31

Next Earnings

05-27

Forward P/E

17.90

Payout Ratio

22.35%

P/FCF (TTM)

31.79

FCF Yield

3.15%

Earnings Yield

4.09%

52 Week Range

Score Card

Explore Scores Tab

3.71

Good

Agilent Technologies Inc has grown revenue at 8.14% over the past year, which suggests sales are increasing. Also, it has seen its diluted average shares outstanding decrease by -1.05% over the past year, which suggests the company is buying back shares.

Valuation Model

Key Score

3.00

Average

Management

2.00

Bad

Growth

3.00

Average

Profitability

3.00

Average

Fin. Health

4.00

Good

Dividends

2.00

Bad

Analyst

2.00

Bad

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

1 new filing was in the last 7 days

Filter Form Types

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-12 16:11:55

Form 3

Initial statement of beneficial ownership of securities - general instructions

Filed on 2026-05-08 16:18:05

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-05-04 08:05:15

Form SCHEDULE 13G

Unknown Form Type

Filed on 2026-04-29 16:42:15

Form SCHEDULE 13G

Unknown Form Type

Filed on 2026-04-28 15:50:24

Form 8-K/A

(Amendment) Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-03 21:30:08

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-03 16:05:10

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-02 16:06:44

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-26 15:12:29

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:39:21

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:36:00

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:29:59

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-04-25

High:

$194.25

73.9%

Avg:

$163.45

46.3%

Low:

$141.40

26.6%

(% change is relative to the current stock price: $111.70)

Analyst Recommendations

Go to Analyst Tab

4.00

Good

21%

Strong Buy (6)

57%

Buy (16)

21%

Hold (6)

Sell (0)

Strong Sell (0)

About

Website
https://www.agilent.com/
Address
5301 Stevens Creek Blvd, Santa Clara CALIFORNIA, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1090872

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,000 full-time employees. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.

IPO Date

1999-11-18

Industry

Life Sciences Tools & Services

Total Employees

18,000

Exchange

New York Stock Exchange, Inc.

Reporting Currency

USD

GICS

Life Sciences Tools & Services

GICS Sub

Life Sciences Tools & Services

GICS Sector

Health Care

GICS Group

Pharmaceuticals, Biotechnology & Life Sciences

A - Agilent Technologies Inc

70

$111.70

-$1.56 (-1.377%)

3.71/5

Stock Unlock

Stock Profile

Score Card

Good

Insider Transactions

Market News

Form 4

Filed on 2026-05-12 16:11:55

Form 3

Filed on 2026-05-08 16:18:05

Form 8-K

Filed on 2026-05-04 08:05:15

Form SCHEDULE 13G

Filed on 2026-04-29 16:42:15

Form SCHEDULE 13G

Filed on 2026-04-28 15:50:24

Form 8-K/A

Filed on 2026-04-03 21:30:08

Form 8-K

Filed on 2026-04-03 16:05:10

Form 4

Filed on 2026-04-02 16:06:44

Form SCHEDULE 13G/A

Filed on 2026-03-26 15:12:29

Form 4

Filed on 2026-03-23 16:39:21

Form 4

Filed on 2026-03-23 16:36:00

Form 4

Filed on 2026-03-23 16:29:59

Financials

Price Targets

73.9%

46.3%

26.6%

Analyst Recommendations

About

Similar Stocks